Brain inflammaging in the pathogenesis of late-life depression

Ismail Z, Fischer C, McCall WV. What characterizes late-life depression? Psychiatr Clin N Am. 2013;36:483–96.

Article  Google Scholar 

Hall CA, Reynolds CF-III. Late-life depression in the primary care setting: challenges, collaborative care, and prevention. Maturitas. 2014;79:147–52.

Article  PubMed  PubMed Central  Google Scholar 

Haigh EAP, Boguchi OE, Sigmon ST, Blazer DG. Depression among older adults: a 20-year update on five common myths and misconceptions. Am J Geriatr Psychiatry. 2018;26:107–22.

Article  PubMed  Google Scholar 

Wilkowska-Chmielewska J, Szelenberger W, Wojnar M. Age-dependent symptomatology of depression in hospitalized patients and its implications for DSM-5. J Affect Disord. 2013;150:142–5.

Article  PubMed  Google Scholar 

Thorlund K, Druyts E, Wu P, Balijepalli C, Keohane D, Mille E. Comparative efficacy and safety of selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors in older adults: a network meta-analysis. J Am Geriatr Soc. 2015;63:1002–9.

Article  PubMed  Google Scholar 

Alexopoulos GS. Mechanisms and treatment of late-life depression. Transl Psychiatry. 2019;9:188.

Article  PubMed  PubMed Central  Google Scholar 

Gruver AL, Hudson LL, Sempowski GD. Immunoscenescence of ageing. J Pathol. 2007;211:144–56.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol Ser A Biol Sci Med Sci. 2014;69:54–9.

Article  Google Scholar 

Forbes M, O’Neil A, Lane M, Agustini B, Myles N, Berk M. Major depressive disorder in older patients as an inflammatory disorder: implications for the pharmacological management of geriatric depression. Drugs Aging. 2021;38:451–67.

Article  PubMed  Google Scholar 

Dantzer R, Oconnor J, Lawson MA, Kelley KW. Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology. 2011;36:426–36.

Article  PubMed  CAS  Google Scholar 

Kiecolt-Glaser JK, Derry HM, Fagundes CP. Inflammation: depression fans the flames and feasts on the heat. Am J Psychiatry. 2015;172:1075–91.

Article  PubMed  PubMed Central  Google Scholar 

Miller AH. Beyond depression: the expanding role of inflammation in psychiatric disorders. World Psychiatry. 2020;19:108–9.

Article  PubMed  PubMed Central  Google Scholar 

Slavich GM, Irwin MR. From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull. 2014;140:774–815.

Article  PubMed  PubMed Central  Google Scholar 

Lucin KM, Wyss-Coray T. Immune activation in brain aging and neurodegeneration: too much or too little? Neuron. 2009;64:110–22.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cianciulli A, Calvello R, Ruggiero M, Panaro MA. Inflammaging and brain: curcumin and its beneficial potential as regulator of microglia activation. Molecules. 2022;27:341.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gorgoulis V, Adams PD, Alimonti A, Bennet DC, Bischof O, Bishop C, et al. Cellular senescence: defining a path forward. Cell. 2019;179:813–27.

Article  PubMed  CAS  Google Scholar 

Streit WJ, Sammons NW, Kuhns AJ, Sparks DI. Dystrophic microglia in the aging human brain. Glia. 2004;45:208–12.

Article  PubMed  Google Scholar 

Streit WJ, Braak H, Xue QS, Bechmann I. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer’s disease. Acta Neuropathol. 2009;118:475–85.

Article  PubMed  PubMed Central  Google Scholar 

Cao D, Li XH, Luo XG, Yu HM, Wan LS, Wei L, et al. Phorbol myristate acetate induces cellular senescence in rat microglia in vitro. Int J Mol Med. 2020;46:415–26.

Article  PubMed  CAS  Google Scholar 

Wong WT. Microglial aging in the healthy CNS: phenotypes, drivers, and rejuvenation. Front Cell Neurosci. 2013;7:22.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ransohoff RM. A polarizing question: do M1 and M2 microglia exist? Nat Neurosci. 2016;19:987–91.

Article  PubMed  CAS  Google Scholar 

Calvello R, Cianciulli A, Nicolardi G, De Nuccio F, Giannotti L, Salvatore R, et al. Vitamin D treatment attenuates neuroinflammation and dopaminergic neurodegeneration in an animal model of Parkinson’s disease, shifting M1 to M2 microglia responses. J Neuroimmune Pharmacol. 2017;12:327–39.

Article  PubMed  Google Scholar 

Guo S, Wang H, Yin Y. Microglia polarization from M1 to M2 in neurodegenerative diseases. Front Aging Neurosci. 2022;14:815347.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cianciulli A, Porro C, Calvello R, Trotta T, Lofrumento DD, Panaro MA. Microglia mediated neuroinflammation: focus on PI3K modulation. Biomolecules. 2020;10:137.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Di Benedetto S, MuAaller L, Wenger E, Duzel S, Pawelec G. Contribution of neuroinflammation and immunity to brain aging and the mitigating effects of physical and cognitive interventions. Neurosci Biobehav Rev. 2017;75:114–28.

Article  PubMed  Google Scholar 

Tian L, Ma L, Kaarela T, Li Z. Neuroimmune crosstalk in the central nervous system and its significance for neurological diseases. J Neuroinflamm. 2012;9:155.

Article  CAS  Google Scholar 

Abott NJ, Patabendige AAK, Dolman DEM, Yusof SR, Begley DJ. Structure and function of the blood–brain barrier. Neurobiol Dis. 2010;37:13–25.

Article  Google Scholar 

Knox EG, Aburto MR, Clarke G, Cryan JF, O’Driscoll JM. The blood–brain barrier in aging and neurodegeneration. Mol Psychiatry. 2022;27:2659–73.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yang AC, Stevens MY, Chen MB, Lee DP, Stahli D, Gate D, et al. Physiological blood–brain transport is impaired with age by a shift in transcytosis. Nature. 2020;583:425–30.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Elahy M, Jackaman C, Mamo JC, Lam V, Dhaliwal SS, Giles C, et al. Blood–brain barrier dysfunction developed during normal aging is associated with inflammation and loss of tight junctions but not with leukocyte recruitment. Immun Ageing. 2015;12:2.

Article  PubMed  PubMed Central  Google Scholar 

Erickson MA, Banks WA. Age-associated changes in the immune system and blood–brain barrier functions. Int J Mol Sci. 2019;20:1632.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, Zhao Z, et al. Blood–brain barrier breakdown in the aging human hippocampus. Neuron. 2015;85:296–302.

Article  PubMed  PubMed Central  CAS 

留言 (0)

沒有登入
gif